Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells.
Pendurthi
Usha R
UR
Biomedical Research, The University of Texas Health Center at Tyler, 11937 US HWY 271, Tyler, TX 75708, USA.
Rao
L Vijaya Mohan
LV
D002448:Cell Adhesion / Q000187:drug effects; D016207:Cytokines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004347:Drug Interactions; D019040:E-Selectin / Q000032:analysis / Q000187:drug effects / Q000235:genetics; D004730:Endothelium, Vascular / Q000166:cytology*; D006801:Humans; D009000:Monocytes / Q000166:cytology* / Q000187:drug effects; D012333:RNA, Messenger / Q000032:analysis / Q000187:drug effects; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014471:Umbilical Veins / Q000166:cytology
D016207:Cytokines; D019040:E-Selectin; D012333:RNA, Messenger; D013267:Stilbenes; D000077185:Resveratrol